REQUEST A DEMO
Total
USD $0.00
Search more companies

Pt Biotech Maju Sejahtera (Indonesia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pt Biotech Maju Sejahtera Profile Updated: November 14, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pt Biotech Maju Sejahtera is a company in Indonesia, with a head office in Bekasi. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on January 19, 2010. In its most recent financial highlights, the company reported a net sales revenue increase of 10.34% in 2024. During that time, Pt Biotech Maju Sejahtera’s total assets grew by 10.79%.

Headquarters
Jl. Musholah Al-Ikhsan No.8
Bekasi; West Java; Postal Code: 17412

Contact Details: Purchase the Pt Biotech Maju Sejahtera report to view the information.

Website: http://www.biotech-ms.co.id

Basic Information
Registered Capital:
Purchase the Pt Biotech Maju Sejahtera report to view the information.
Financial Auditors:
Purchase the Pt Biotech Maju Sejahtera report to view the information.
Incorporation Date:
January 19, 2010
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Commissioner
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pt Biotech Maju Sejahtera report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
10.34%
Total Operating Revenue
10.34%
Total Assets
10.79%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?